Dicyclomine Hydrochloride

Product NDC: 53002-3450
11-digit product format: 530023450
Labeler code: 53002
Product ID: 53002-3450_29a0eadf-ea2e-46b6-aeca-2618d5d47ff3
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Dicyclomine Hydrochloride
Dosage form: TABLET
Route: ORAL
Labeler: RPK Pharmaceuticals, Inc.
Application: ANDA085223
Marketing category: ANDA
Marketing start: 1986-07-30
Marketing end: 0000-00-00
Substance: DICYCLOMINE HYDROCHLORIDE
Active strength: 20 mg/1
Pharmacologic classes: Anticholinergic [EPC],Cholinergic Antagonists [MoA]
NDC exclude flag: No
Listing certified through: 2021-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 4 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	53002-3450		I	Inactivated by FDA	2026-08-11
excluded package	package	53002-3450	53002-3450-1	I	Inactivated by FDA	2026-08-11
excluded package	package	53002-3450	53002-3450-2	I	Inactivated by FDA	2026-08-11
excluded package	package	53002-3450	53002-3450-3	I	Inactivated by FDA	2026-08-11

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 44 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	53002-3450-1	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	53002-3450-3	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	53002-3450-2	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	53002-3450-1	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	53002-3450-3	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	53002-3450-2	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	53002-3450-1	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	53002-3450-3	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	53002-3450-2	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	53002-3450-1	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	53002-3450-3	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	53002-3450-2	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	53002-3450-1	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	53002-3450-3	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	53002-3450-2	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	53002-3450-1	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	53002-3450-3	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	53002-3450-2	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	53002-3450-2	U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	53002-3450-1	U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	53002-3450-3	U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	53002-3450-2	U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	53002-3450-1	U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	53002-3450-3	U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	53002-3450-2	U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	53002-3450-1	U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	53002-3450-3	U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded product	product		I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	53002-3450-1	I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	53002-3450-2	I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	53002-3450-3	I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded product	product		I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded package	package	53002-3450-3	I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded package	package	53002-3450-1	I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded package	package	53002-3450-2	I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A085223-001	DICYCLOMINE HYDROCHLORIDE	DICYCLOMINE HYDROCHLORIDE	20MG	TABLET / ORAL	AB	RS	1986-07-30

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-product	TE code
A085223-001	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A085223-001	DICYCLOMINE HYDROCHLORIDE	20MG	TABLET / ORAL	AB	RS	1986-07-30	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A085223-001	DICYCLOMINE HYDROCHLORIDE	20MG	TABLET / ORAL	AB	RS	1986-07-30	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A085223-001	DICYCLOMINE HYDROCHLORIDE	20MG	TABLET / ORAL	AB	RS	1986-07-30	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A085223-001	DICYCLOMINE HYDROCHLORIDE	20MG	TABLET / ORAL	AB	RS	1986-07-30	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A085223-001	DICYCLOMINE HYDROCHLORIDE	20MG	TABLET / ORAL	AB	RS	1986-07-30	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A085223-001	DICYCLOMINE HYDROCHLORIDE	20MG	TABLET / ORAL	AB	RS	1986-07-30	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A085223-001	DICYCLOMINE HYDROCHLORIDE	20MG	TABLET / ORAL	AB	RS	1986-07-30	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A085223-001	DICYCLOMINE HYDROCHLORIDE	20MG	TABLET / ORAL	AB	RS	1986-07-30	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A085223-001	DICYCLOMINE HYDROCHLORIDE	20MG	TABLET / ORAL	AB	RS	1986-07-30	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A085223-001	DICYCLOMINE HYDROCHLORIDE	20MG	TABLET / ORAL	AB	RS	1986-07-30	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A085223-001	DICYCLOMINE HYDROCHLORIDE	20MG	TABLET / ORAL	AB	RS	1986-07-30	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A085223-001	DICYCLOMINE HYDROCHLORIDE	20MG	TABLET / ORAL	AB	RS	1986-07-30	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A085223-001	DICYCLOMINE HYDROCHLORIDE	20MG	TABLET / ORAL	AB	RS	1986-07-30	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A085223-001	DICYCLOMINE HYDROCHLORIDE	20MG	TABLET / ORAL	AB	RS	1986-07-30	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A085223-001	DICYCLOMINE HYDROCHLORIDE	20MG	TABLET / ORAL	AB	RS	1986-07-30	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A085223-001	DICYCLOMINE HYDROCHLORIDE	20MG	TABLET / ORAL	AB	RS	1986-07-30	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A085223-001	DICYCLOMINE HYDROCHLORIDE	20MG	TABLET / ORAL	AB	RS	1986-07-30	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A085223-001	DICYCLOMINE HYDROCHLORIDE	20MG	TABLET / ORAL	AB		1986-07-30	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A085223-001	DICYCLOMINE HYDROCHLORIDE	20MG	TABLET / ORAL	AB	RS	1986-07-30	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A085223-001	DICYCLOMINE HYDROCHLORIDE	20MG	TABLET / ORAL	AB	RS	1986-07-30	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A085223-001	DICYCLOMINE HYDROCHLORIDE	20MG	TABLET / ORAL	AB	RS	1986-07-30	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A085223-001	DICYCLOMINE HYDROCHLORIDE	20MG	TABLET / ORAL	AB	RS	1986-07-30	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A085223-001	DICYCLOMINE HYDROCHLORIDE	20MG	TABLET / ORAL	AB	RS	1986-07-30	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A085223-001	DICYCLOMINE HYDROCHLORIDE	20MG	TABLET / ORAL	AB	RS	1986-07-30	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A085223-001	DICYCLOMINE HYDROCHLORIDE	20MG	TABLET / ORAL	AB		1986-07-30	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A085223-001	DICYCLOMINE HYDROCHLORIDE	20MG	TABLET / ORAL	AB		1986-07-30	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A085223-001	DICYCLOMINE HYDROCHLORIDE	20MG	TABLET / ORAL	AB		1986-07-30	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A085223-001	DICYCLOMINE HYDROCHLORIDE	20MG	TABLET / ORAL	AB	RS	1986-07-30	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A085223-001	DICYCLOMINE HYDROCHLORIDE	20MG	TABLET / ORAL	AB	RS	1986-07-30	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A085223-001	DICYCLOMINE HYDROCHLORIDE	20MG	TABLET / ORAL	AB	RS	1986-07-30	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A085223-001	DICYCLOMINE HYDROCHLORIDE	20MG	TABLET / ORAL	AB	RS	1986-07-30	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A085223-001	DICYCLOMINE HYDROCHLORIDE	20MG	TABLET / ORAL	AB	RS	1986-07-30	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A085223-001	DICYCLOMINE HYDROCHLORIDE	20MG	TABLET / ORAL	AB	RS	1986-07-30	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A085223-001	DICYCLOMINE HYDROCHLORIDE	20MG	TABLET / ORAL	AB	RS	1986-07-30	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A085223-001	DICYCLOMINE HYDROCHLORIDE	20MG	TABLET / ORAL	AB	RS	1986-07-30	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A085223-001	DICYCLOMINE HYDROCHLORIDE	20MG	TABLET / ORAL	AB	RS	1986-07-30	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A085223-001	DICYCLOMINE HYDROCHLORIDE	20MG	TABLET / ORAL	AB	RS	1986-07-30	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A085223-001	DICYCLOMINE HYDROCHLORIDE	20MG	TABLET / ORAL	AB	RS	1986-07-30	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	A085223-001	DICYCLOMINE HYDROCHLORIDE	20MG	TABLET / ORAL	AB	RS	1986-07-30	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	A085223-001	DICYCLOMINE HYDROCHLORIDE	20MG	TABLET / ORAL	AB	RS	1986-07-30	`cb3db0bc1861…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A085223-001	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A085223-001	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A085223-001	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A085223-001	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A085223-001	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A085223-001	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A085223-001	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A085223-001	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A085223-001	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A085223-001	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A085223-001	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A085223-001	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A085223-001	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A085223-001	AB	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A085223-001	AB	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A085223-001	AB	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A085223-001	AB	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A085223-001	AB	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A085223-001	AB	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A085223-001	AB	1	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A085223-001	AB	1	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A085223-001	AB	1	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A085223-001	AB	1	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A085223-001	AB	1	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A085223-001	AB	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A085223-001	AB	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A085223-001	AB	1	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A085223-001	AB	1	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A085223-001	AB	1	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A085223-001	AB	1	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A085223-001	AB	1	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A085223-001	AB	1	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A085223-001	AB	1	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A085223-001	AB	1	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A085223-001	AB	1	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A085223-001	AB	1	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A085223-001	AB	1	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A085223-001	AB	1	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	A085223-001	AB	1	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	A085223-001	AB	1	`cb3db0bc1861…`

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
f755a917-03bc-45af-a1e3-50286868bfdb	Product name	9	20250303
f27796e1-d653-495b-932a-f51768e9be8a	Product name	2	20211021

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Related label table
NDC	Effective	Related label
53002-3450-1	2025-01-30	These highlights do not include all the information needed to use DICYCLOMINE HYDROCHLORIDE safely and effectively. See full prescribing information for DICYCLOMINE HYDROCHLORIDE. DICYCLOMINE HYDROCHLORIDE capsules, for oral use DICYCLOMINE HYDROCHLORIDE tablets, for oral use Initial U.S. Approval: 1950
53002-3450-2	2025-01-30	These highlights do not include all the information needed to use DICYCLOMINE HYDROCHLORIDE safely and effectively. See full prescribing information for DICYCLOMINE HYDROCHLORIDE. DICYCLOMINE HYDROCHLORIDE capsules, for oral use DICYCLOMINE HYDROCHLORIDE tablets, for oral use Initial U.S. Approval: 1950
53002-3450-3	2025-01-30	These highlights do not include all the information needed to use DICYCLOMINE HYDROCHLORIDE safely and effectively. See full prescribing information for DICYCLOMINE HYDROCHLORIDE. DICYCLOMINE HYDROCHLORIDE capsules, for oral use DICYCLOMINE HYDROCHLORIDE tablets, for oral use Initial U.S. Approval: 1950
53002-3450-1	2023-06-07	These highlights do not include all the information needed to use DICYCLOMINE HYDROCHLORIDE safely and effectively. See full prescribing information for DICYCLOMINE HYDROCHLORIDE. DICYCLOMINE HYDROCHLORIDE capsules, for oral use DICYCLOMINE HYDROCHLORIDE tablets, for oral use Initial U.S. Approval: 1950
53002-3450-2	2023-06-07	These highlights do not include all the information needed to use DICYCLOMINE HYDROCHLORIDE safely and effectively. See full prescribing information for DICYCLOMINE HYDROCHLORIDE. DICYCLOMINE HYDROCHLORIDE capsules, for oral use DICYCLOMINE HYDROCHLORIDE tablets, for oral use Initial U.S. Approval: 1950
53002-3450-3	2023-06-07	These highlights do not include all the information needed to use DICYCLOMINE HYDROCHLORIDE safely and effectively. See full prescribing information for DICYCLOMINE HYDROCHLORIDE. DICYCLOMINE HYDROCHLORIDE capsules, for oral use DICYCLOMINE HYDROCHLORIDE tablets, for oral use Initial U.S. Approval: 1950
53002-3450-1	2023-01-30	These highlights do not include all the information needed to use DICYCLOMINE HYDROCHLORIDE safely and effectively. See full prescribing information for DICYCLOMINE HYDROCHLORIDE. DICYCLOMINE HYDROCHLORIDE capsules, for oral use DICYCLOMINE HYDROCHLORIDE tablets, for oral use Initial U.S. Approval: 1950
53002-3450-2	2023-01-30	These highlights do not include all the information needed to use DICYCLOMINE HYDROCHLORIDE safely and effectively. See full prescribing information for DICYCLOMINE HYDROCHLORIDE. DICYCLOMINE HYDROCHLORIDE capsules, for oral use DICYCLOMINE HYDROCHLORIDE tablets, for oral use Initial U.S. Approval: 1950
53002-3450-3	2023-01-30	These highlights do not include all the information needed to use DICYCLOMINE HYDROCHLORIDE safely and effectively. See full prescribing information for DICYCLOMINE HYDROCHLORIDE. DICYCLOMINE HYDROCHLORIDE capsules, for oral use DICYCLOMINE HYDROCHLORIDE tablets, for oral use Initial U.S. Approval: 1950
53002-3450-1	2020-12-15	These highlights do not include all the information needed to use DICYCLOMINE HYDROCHLORIDE safely and effectively. See full prescribing information for DICYCLOMINE HYDROCHLORIDE. DICYCLOMINE HYDROCHLORIDE capsules, for oral use DICYCLOMINE HYDROCHLORIDE tablets, for oral use Initial U.S. Approval: 1950
53002-3450-2	2020-12-15	These highlights do not include all the information needed to use DICYCLOMINE HYDROCHLORIDE safely and effectively. See full prescribing information for DICYCLOMINE HYDROCHLORIDE. DICYCLOMINE HYDROCHLORIDE capsules, for oral use DICYCLOMINE HYDROCHLORIDE tablets, for oral use Initial U.S. Approval: 1950
53002-3450-3	2020-12-15	These highlights do not include all the information needed to use DICYCLOMINE HYDROCHLORIDE safely and effectively. See full prescribing information for DICYCLOMINE HYDROCHLORIDE. DICYCLOMINE HYDROCHLORIDE capsules, for oral use DICYCLOMINE HYDROCHLORIDE tablets, for oral use Initial U.S. Approval: 1950
53002-3450-1	2020-01-31	These highlights do not include all the information needed to use DICYCLOMINE HYDROCHLORIDE safely and effectively. See full prescribing information for DICYCLOMINE HYDROCHLORIDE. DICYCLOMINE HYDROCHLORIDE capsules, for oral use DICYCLOMINE HYDROCHLORIDE tablets, for oral use Initial U.S. Approval: 1950
53002-3450-2	2020-01-31	These highlights do not include all the information needed to use DICYCLOMINE HYDROCHLORIDE safely and effectively. See full prescribing information for DICYCLOMINE HYDROCHLORIDE. DICYCLOMINE HYDROCHLORIDE capsules, for oral use DICYCLOMINE HYDROCHLORIDE tablets, for oral use Initial U.S. Approval: 1950
53002-3450-3	2020-01-31	These highlights do not include all the information needed to use DICYCLOMINE HYDROCHLORIDE safely and effectively. See full prescribing information for DICYCLOMINE HYDROCHLORIDE. DICYCLOMINE HYDROCHLORIDE capsules, for oral use DICYCLOMINE HYDROCHLORIDE tablets, for oral use Initial U.S. Approval: 1950

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
53002-3450-1	Dicyclomine Hydrochloride	10 in 1 BOTTLE	TABLET	10	8
53002-3450-2	Dicyclomine Hydrochloride	20 in 1 BOTTLE	TABLET	20	8
53002-3450-3	Dicyclomine Hydrochloride	30 in 1 BOTTLE	TABLET	30	8

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
53002-3450	DICYCLOMINE HYDROCHLORIDE CAPSULE DICYCLOMINE HYDROCHLORIDE TABLET [RPK PHARMACEUTICALS, INC.]	8	Legacy NDC, 3 package rows	20230609_7cbefee1-1b23-4e9b-8527-ec357a9dbcb6.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 5 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Dicyclomine Hydrochloride	DICYCLOMINE HYDROCHLORIDE	Northwind Health Company, LLC	c195b8ea-c1bf-453f-e053-2a95a90a2121	2026-01-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 085223 application number: ANDA085223
Dicyclomine Hydrochloride	DICYCLOMINE HYDROCHLORIDE	PD-Rx Pharmaceuticals, Inc.	da0e1f63-cb90-4c2a-908f-7d81e672be10	2025-01-07	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 085223 application number: ANDA085223
Dicyclomine Hydrochloride	DICYCLOMINE HYDROCHLORIDE	NuCare Pharmaceuticals, Inc.	517646d8-366e-5cf2-e054-00144ff88e88	2024-07-08	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 085223 application number: ANDA085223
Dicyclomine Hydrochloride	DICYCLOMINE HYDROCHLORIDE	Actavis Pharma, Inc.	a5937c7b-cdfc-46e6-a0fa-541b24f91d47	2024-04-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 085223 application number: ANDA085223
Dicyclomine Hydrochloride	DICYCLOMINE HYDROCHLORIDE	Proficient Rx LP	bd8b7fcd-04f4-4d1c-aa27-743aaf4c2876	2022-03-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 085223 application number: ANDA085223

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
CQ903KQA31	DICYCLOMINE HYDROCHLORIDE	67-92-5	DICYCLOMINE HYDROCHLORIDE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
991061	dicyclomine HCl 10 MG Oral Capsule	PSN	7cbefee1-1b23-4e9b-8527-ec357a9dbcb6	8
991086	dicyclomine HCl 20 MG Oral Tablet	PSN	7cbefee1-1b23-4e9b-8527-ec357a9dbcb6	8
991061	dicyclomine hydrochloride 10 MG Oral Capsule	SCD	7cbefee1-1b23-4e9b-8527-ec357a9dbcb6	8
991086	dicyclomine hydrochloride 20 MG Oral Tablet	SCD	7cbefee1-1b23-4e9b-8527-ec357a9dbcb6	8

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
53002-3450-1	53002345001	10 TABLET in 1 BOTTLE (53002-3450-1)	10 tablet	2018-10-01	0000-00-00	No	No	Current
53002-3450-2	53002345002	20 TABLET in 1 BOTTLE (53002-3450-2)	20 tablet	2018-10-01	0000-00-00	No	No	Current
53002-3450-3	53002345003	30 TABLET in 1 BOTTLE (53002-3450-3)	30 tablet	2018-10-01	0000-00-00	No	No	Current